IPOPEMA Securities S.A. (IPE.WA) operates as a leading Polish brokerage house and investment banking firm, providing comprehensive financial services including brokerage, equity research, investment banking advisory, portfolio management, and asset management to institutional, corporate, and individual clients. The company offers core products and services such as brokerage and related activities on the Warsaw Stock Exchange (WSE), Budapest Stock Exchange (BSE), and Prague Stock Exchange (PSE); analytical reports on listed companies in Poland and Central and Eastern Europe (CEE); investment banking services encompassing mergers and acquisitions advisory, capital market transactions, and structured certificates like express certificates on equities such as CCC; portfolio and investment fund management through its subsidiary IPOPEMA TFI S.A.; and financial advisory including restructuring, funding for infrastructure projects, and IT systems implementation via IPOPEMA Financial Advisory. It serves institutional investors, insurance companies, non-profit organizations, retail investors, and corporates primarily in Poland with regional reach across CEE markets. Founded in 2005 and headquartered at 9 Próżna Street in Warsaw, Poland, the firm manages a group that includes subsidiaries focused on fund investments and financial advisory. Among its latest major developments, IPOPEMA Securities acted as financial adviser in October 2025 for the preliminary sale of 100% of shares in travel services provider Why Not Travel to eTravel S.A., a portfolio company of Enterprise Investors, underscoring its role in facilitating consolidation in Poland's travel sector; the firm continues active capital market offerings, including subscriptions for structured certificates like IPOPEMA Benefit 3 FIZ AN series AAG and Eques funds in November 2025, Smyk Holding S.A. shares in October 2025, and CCC equity-linked certificates.